Meet the Team - Dr Sonya Miller
Introducing Dr Sonya Miller
The second in our Meet the Team video series which introduces some of the people who contribute to the important work of TauRx, is now available to view.
Dr Sonya Miller, TauRx Medical Oversight Lead, discusses her work within TauRx, what she enjoys about being part of the team and a hope for the future of Alzheimer's disease treatment.
Look out for future Meet the Team videos! Watch Dr Sonya Miller's video here or below.
Recent News
LUCIDITY phase 3 topline data presented at CTAD for HMTM - the only oral anti-Tau therapy in late-stage development
Dec 02, 2022
TauRx Announces Additional Investment of USD119 million following announcement of Phase 3 LUCIDITY Topline Results
Nov 14, 2022
TauRx Pharmaceuticals Ltd has announced further results from its Phase 3 LUCIDITY trial for Hydromethylthionine mesylate (HMTM)
Oct 06, 2022
TauRx Pharmaceuticals Ltd is delighted to name Dr Richard Stefanacci, an established global key opinion leader in Alzheimer’s, as Chief Medical Officer (CMO)
Oct 06, 2022